Gregory A. Petsko
Chairman of Scientific Advisory BoardProf. Dr. Gregory A. Petsko, also known as Greg, D.Phil., Ph.D., is Scientific Co-Founder of Retromer Therapeutics, Inc. He serves as an Adjunct Professor of Department of Neurology and Center For Neurologic Diseases, Harvard Medical School. He serves as an Adjunct Professor of Biomedical Engineering at Cornell University. He is a Gyula and Katica Tauber Professor for Department of Biochemistry and Department of Chemistry at Rosenstiel Basic Medical Sciences Research Center, Brandeis University. His areas of expertise is protein crystallography, where he studies the three-dimensional structures of proteins and their biochemical functions. He serves as the Chairman of Scientific Advisory Board of MeiraGTx Holdings plc (formerly known as MeiraGTx Limited). He serves as a Member of Advisory Board of MediQuest Therapeutics, Inc. He serves as a Member of Scientific Advisory Board of Fisher BioImage ApS and Adnexus Therapeutics, Inc. He has been a Member of Scientific Advisory Board of Annovis Bio, Inc. since January 24, 2017. He served as a Member of Medical Advisory Board of Howard Hughes Medical Institute. He serves as a Member of Scientific Advisory Board of Link Medicine Corporation and Scientific Advisor of NeuroPhage Pharmaceuticals, Inc. He served as a Member of Scientific Advisory Board of Amicus Therapeutics, Inc. He served as a Member of Bioethics Advisory Board at Healthcare IT, Inc. He served as a Member of Scientific Advisory Board of MannKind Corp. and Caprion Pharmaceuticals, Inc. He served as a Member of the Institutional Advisory Board at VIB. B.V. He serves as Director of Rosenstiel Basic Medical Sciences Research Center, Brandeis University. He serves as a Director of Helen and Robert Appel Alzheimer'sDisease Research Institute at Weill Cornell Medical College. He is a Member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. His research interests are in neurological diseases like Alzheimer's, Parkinson's and ALS; discovering treatments (especially by using structure-based drug design and seeing any resulting drug candidates tested in humans. He received numerous honors including Lynen Medal, Guggenheim Foundation Fellowship, Max Plack Prize, Alexander von Humboldt Senior Scientist Award and Pfizer Awards in Enzyme Chemistry (American Chemical Society) in 1986 and is a Member of the National Academy of Sciences. He received his D. Phil. in Molecular Biophysics from Oxford University as a Rhodes Scholar and his BA from Princeton University.
Positions
- Company NameMeiraGTx Holdings plcStock CodeMGTXPositionChairman of Scientific Advisory BoardColleagues
- AFAlexandria ForbesCEO, President & Director
- KRKeith Reginald HarrisIndependent Chairman of the Board
- RBRichard Brian GirouxCOO & CFO
- RKRobert K. ZeldinChief Medical Officer
- RJRobert J. WollinGeneral Counsel & Secretary
- SNStuart NaylorChief Scientific Officer of Ophthalmology
- NSNicole SeligmanIndependent Director
- TEThomas E. ShenkIndependent Director & Member of Scientific Advisory Board
